{
    "body": "Which translocation is the hallmark of Ewing sarcoma?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22266186", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10030577", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24124617", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23145994", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22742646", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16864960", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21422656", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21942527", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16083345", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15919668", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18971581", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15274413", 
        "http://www.ncbi.nlm.nih.gov/pubmed/6416622", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25401475", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22240531", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21653923"
    ], 
    "ideal_answer": [
        "Tumours defined as Ewing sarcoma (ES) constitute a group of highly malignant neoplasms that most often affect children and young adults in the first 2 decades of life. The EWS/Fli-1 fusion gene, a product of the translocation t(11;22) (q24; 12), is detected in 95% of ES patients", 
        "The EWS/Fli-1 fusion gene, a product of the translocation t(11;22) (q24;12), is detected in 95% of Ewing sarcoma patients.", 
        "The hallmark of Ewing s sarcoma (EWS) is a translocation--t(11;22)(q24;q12)--that most frequently results in the EWS/FLI1 aberrant chimeric gene  "
    ], 
    "exact_answer": [
        "translocation t(11;22) (q24;12)"
    ], 
    "concepts": [
        "http://www.disease-ontology.org/api/metadata/DOID:3368", 
        "http://www.disease-ontology.org/api/metadata/DOID:4980", 
        "http://www.disease-ontology.org/api/metadata/DOID:4232", 
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012512"
    ], 
    "type": "factoid", 
    "id": "552faababc4f83e828000005", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 279, 
            "text": "Tumours defined as Ewing sarcoma (ES) constitute a group of highly malignant neoplasms that most often affect children and young adults in the first 2 decades of life. The EWS/Fli-1 fusion gene, a product of the translocation t(11;22) (q24; 12), is detected in 95% of ES patients", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24124617", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 12, 
            "offsetInEndSection": 199, 
            "text": "Ewing's sarcoma is a malignancy characterized by a specific 11:22 chromosomal translocation which generates a novel EWS-FLI1 fusion protein functioning as an aberrant transcription factor", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23145994", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 144, 
            "text": "The hallmark of Ewing's sarcoma (EWS) is a translocation--t(11;22)(q24;q12)--that most frequently results in the EWS/FLI1 aberrant chimeric gene", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22742646", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 147, 
            "text": "The chromosomal translocation t(11;22)(q24;q12) yields the EWS-Fli1 fusion gene, which contributes to the development of Ewing Family Tumors (EFTs)", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266186", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 12, 
            "offsetInEndSection": 82, 
            "text": "Ewing sarcoma is extremely rare in people from East and Southeast Asia", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22240531", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1064, 
            "offsetInEndSection": 1141, 
            "text": "The t(11;22)(q24:q12) translocation was present in all patients in our series", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22240531", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1155, 
            "offsetInEndSection": 1318, 
            "text": "We confirmed that distant metastases is highly predictive of a poor outcome, and that the t(11;22)(q24:q12) translocation was present in all patients in our series", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22240531", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 281, 
            "text": "The genetic hallmark of the Ewing sarcoma family of tumours (ESFT) is the presence of the t(11;22)(q24;q12) translocation, present in up to 85% of cases of ESFT, which creates the EWS/FLI1 fusion gene and results in the expression of a chimeric protein regulating many other genes.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16083345", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 134, 
            "offsetInEndSection": 424, 
            "text": "Ewing sarcoma family of tumors (ESFTs) are characterized by the t(11;22)(q24;q12) translocation that generates the Ewing sarcoma breakpoint region 1 and Friend leukemia virus integration 1 (EWS-FLI1) fusion transcription factor responsible for the highly malignant phenotype of this tumor.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21653923", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 661, 
            "offsetInEndSection": 770, 
            "text": "The chromosomal translocation producing the EWS/FLI1 fusion transcript characterizes clinical Ewing sarcoma.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21422656", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 123, 
            "text": "Translocation of chromosomes 11 and 22 in choroidal metastatic Ewing sarcoma detected by fluorescent in situ hybridization.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10030577", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 632, 
            "offsetInEndSection": 778, 
            "text": "Molecular detection of the t(11;22)(q24;q12) translocation in Ewing sarcoma is valuable in the differential diagnosis of small round cell tumors.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10030577", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 652, 
            "offsetInEndSection": 818, 
            "text": "This patient illustrates the second reported occurrence of primary Ewing sarcoma in the stomach and the first reported with the t(11;22)(q24;q12) gene translocation.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18971581", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 142, 
            "text": "Translocations involving ETS-transcription factors, most commonly leading to the EWSR1-FLI1 fusion protein, are the hallmark of Ewing sarcoma.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24974828", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 223, 
            "text": "EWS-Fli1, a fusion gene resulting from a chromosomal translocation t(11;22, q24;q12) and found in Ewing sarcoma and primitive neuroectodermal tumors, encodes a transcriptional activator and promotes cellular transformation.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15919668", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 744, 
            "offsetInEndSection": 957, 
            "text": "The presence of the t(11;22)(q24;ql2) translocation should probably not be considered diagnostic of Ewing sarcoma and peripheral primitive neuroectodermal tumor in the absence of supporting histological evidence.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8644855", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 69, 
            "offsetInEndSection": 417, 
            "text": "Ewing sarcoma is the prototypical member of this group of sarcomas; it was the first to be recognized pathologically as a singular entity and to have its signature translocation defined cytogenetically, which led to the identification of its key driver alteration, the EWS-FLI1 gene fusion that encodes this aberrant, chimeric transcription factor.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21942527", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 144, 
            "text": "The hallmark of Ewings sarcoma (EWS) is a translocation--t(11;22)(q24;q12)--that most frequently results in the EWS/FLI1 aberrant chimeric gene.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22742646", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 148, 
            "offsetInEndSection": 437, 
            "text": "Ewing sarcoma family of tumors (ESFTs) are characterized by the t(11;22)(q24;q12) translocation that generates the Ewing sarcoma breakpoint region 1 and Friend leukemia virus integration 1 (EWS-FLI1) fusion transcription factor responsible for the highly malignant phenotype of this tumor.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21653923", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 658, 
            "offsetInEndSection": 823, 
            "text": "This patient illustrates the second reported occurrence of primary Ewing sarcoma in the stomach and the first reported with the t(11;22)(q24;q12) gene translocation.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18971581", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 231, 
            "offsetInEndSection": 445, 
            "text": "Diagnosis is based on history, immunostaining with at least 2 neural markers, ultrastructural examination, and evidence of an abnormal t(11;22)(q24;q12) translocation as the hallmark for the Ewing's sarcoma family.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15274413", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 421, 
            "offsetInEndSection": 562, 
            "text": "The translocation results in the fusion of the EWS gene with the transcription factor gene FLI1 which has been considered a hallmark of ESFT.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16864960", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 70, 
            "text": "[Chromosomal translocation (11; 22) in cell lines of Ewing's sarcoma].", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/6416622", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 187, 
            "offsetInEndSection": 409, 
            "text": "These results, associated with those obtained at the same time and independently from fresh tumor cells, suggest that the translocation t(11; 22)(q24; q12) may be a chromosomal marker characteristic of Ewing sarcoma cells.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/6416622", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 169, 
            "text": "Chromosomal translocation that results in fusion of the genes encoding RNA-binding protein EWS and transcription factor FLI1 (EWS-FLI1) is pathognomonic for Ewing sarcoma", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25401475", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 231, 
            "offsetInEndSection": 444, 
            "text": "Diagnosis is based on history, immunostaining with at least 2 neural markers, ultrastructural examination, and evidence of an abnormal t(11;22)(q24;q12) translocation as the hallmark for the Ewing's sarcoma family", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15274413", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 141, 
            "text": "Translocations involving ETS-transcription factors, most commonly leading to the EWSR1-FLI1 fusion protein, are the hallmark of Ewing sarcoma", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24974828", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 280, 
            "text": "The genetic hallmark of the Ewing sarcoma family of tumours (ESFT) is the presence of the t(11;22)(q24;q12) translocation, present in up to 85% of cases of ESFT, which creates the EWS/FLI1 fusion gene and results in the expression of a chimeric protein regulating many other genes", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16083345", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 421, 
            "offsetInEndSection": 561, 
            "text": "The translocation results in the fusion of the EWS gene with the transcription factor gene FLI1 which has been considered a hallmark of ESFT", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16864960", 
            "endSection": "abstract"
        }
    ]
}